News

2 May
2022

The Asteria Single-cell RNA-seq Kit and the Cytonaut Cloud Software are here!

Asteria©, our latest breakthrough single-cell RNA-sequencing kit, is now commercially available for all researchers worldwide. This innovative hydrogel-based benchtop kit enables the transcriptomic profiling of 10,000 individual cells per sample, instrument-free. By purchasing the kit, researchers also gain access to its intuitive and entirely cloud-based analysis software Cytonaut©.

The combination of the kit and software is a comprehensive end-to-end single-cell solution – sequencing excepted – accessible to any scientist with or without prior knowledge of single-cell technology and bioinformatics.

 

A single Asteria kit includes all reagents and consumables to process 4 samples of 10,000 cells each directly on the lab bench, with an intuitive protocol including 5 stopping points to adapt to any schedule and timing of fresh samples.

For use with Asteria, Scipio bioscience developed Cytonaut, an end-to-end software solution covering pre- and post-processing analysis as well as interactive data visualization and generation of publication-ready results and figures. Hosted in a secure cloud infrastructure, it guides the user through the analysis step by step, enables researchers to free themselves from heavy computing resources and let them exploit their data without prerequired knowledge in bioinformatics.

You can read about Asteria’s technology and performance on our website, download documentation and even test out for free the Cytonaut software with demo data

To distribute the Asteria single-cell RNA-seq kit, Scipio bioscience has partnered with distributors Witec AG in Switzerland, BioCat in Austria and Germany, Ozyme in France, and Thistle Scientific in the UK and Ireland. For any other countries, orders can be made directly to us here.

Early purchases will benefit from a substantially lower innovator’s price.

 

Scipio Distirbutors

Newsletter

Sign up to receive hands-on tips, technical reviews and experts opinions about single-cell technology. Every two months in your mailbox.